Raffles Medical Group Ltd
SGX:BSL
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.86
1.09
|
Price Target |
|
We'll email you a reminder when the closing price reaches SGD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one BSL stock under the Base Case scenario is 1.01 SGD. Compared to the current market price of 0.86 SGD, Raffles Medical Group Ltd is Undervalued by 15%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Raffles Medical Group Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for BSL cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
Raffles Medical Group Ltd
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Raffles Medical Group Ltd
Balance Sheet Decomposition
Raffles Medical Group Ltd
Current Assets | 476m |
Cash & Short-Term Investments | 316.3m |
Receivables | 148.2m |
Other Current Assets | 11.5m |
Non-Current Assets | 1B |
Long-Term Investments | 246.1m |
PP&E | 762m |
Intangibles | 18.8m |
Other Non-Current Assets | 15.1m |
Current Liabilities | 397.1m |
Accounts Payable | 213.5m |
Short-Term Debt | 112.4m |
Other Current Liabilities | 71.3m |
Non-Current Liabilities | 104.6m |
Long-Term Debt | 76.9m |
Other Non-Current Liabilities | 27.7m |
Earnings Waterfall
Raffles Medical Group Ltd
Revenue
|
701.8m
SGD
|
Cost of Revenue
|
-45.7m
SGD
|
Gross Profit
|
656.1m
SGD
|
Operating Expenses
|
-575.7m
SGD
|
Operating Income
|
80.4m
SGD
|
Other Expenses
|
-19.4m
SGD
|
Net Income
|
60.9m
SGD
|
Free Cash Flow Analysis
Raffles Medical Group Ltd
SGD | |
Free Cash Flow | SGD |
BSL Profitability Score
Profitability Due Diligence
Raffles Medical Group Ltd's profitability score is 56/100. The higher the profitability score, the more profitable the company is.
Score
Raffles Medical Group Ltd's profitability score is 56/100. The higher the profitability score, the more profitable the company is.
BSL Solvency Score
Solvency Due Diligence
Raffles Medical Group Ltd's solvency score is 72/100. The higher the solvency score, the more solvent the company is.
Score
Raffles Medical Group Ltd's solvency score is 72/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
BSL Price Targets Summary
Raffles Medical Group Ltd
According to Wall Street analysts, the average 1-year price target for BSL is 1.12 SGD with a low forecast of 0.97 SGD and a high forecast of 1.47 SGD.
Dividends
Current shareholder yield for BSL is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Raffles Medical Group Ltd. is an investment holding company, which engages in the operation of medical clinics and other general medical services. The firm is focused on providing a range of services from primary and tertiary care to health insurance for people across Asia. The firm operates approximately 100 multi-disciplinary clinics in 14 cities in Singapore, China, Japan, Vietnam and Cambodia. The firm's integrated healthcare organization consists of a tertiary hospital, a network of family medicine and dental clinics, insurance services, Japanese and Traditional Chinese medicine clinics, and a consumer healthcare division. Its healthcare division develops and distributes a range of nutraceuticals, supplements, vitamins and medical diagnostic equipment for personal healthcare in Singapore and in the regional markets. The Company’s subsidiaries include Raffles Medical, Raffles Hospital, Raffles Dental, Raffles Chinese Medicine, Raffles Health Insurance, Raffles Healthcare Institute and Raffles Health.
Contact
IPO
Employees
Officers
The intrinsic value of one BSL stock under the Base Case scenario is 1.01 SGD.
Compared to the current market price of 0.86 SGD, Raffles Medical Group Ltd is Undervalued by 15%.